- Home
- ALHC
as 10-02-2025 4:00pm EST
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 2.7B | IPO Year: | 2021 |
| Target Price: | $18.14 | AVG Volume (30 days): | 4.7M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.15 - $21.06 | Next Earning Date: | 10-30-2025 |
| Revenue: | $3,335,894,000 | Revenue Growth: | 49.46% |
| Revenue Growth (this year): | 47.18% | Revenue Growth (next year): | 28.47% |
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| GENERAL ATLANTIC, L.P. | ALHC | Director, 10% Owner | Sep 17 '25 | Sell | $16.01 | 6,246,096 | $99,999,996.96 | 24,596,079 | |
| General Atlantic (ALN HLTH), L.P. | ALHC | Director, 10% Owner | Sep 17 '25 | Sell | $16.01 | 6,246,096 | $99,999,996.96 | 24,596,079 | |
| KONOWIECKI JOSEPH S | ALHC | Director | Sep 16 '25 | Sell | $16.24 | 16,076 | $261,074.24 | 1,110,973 | |
| GENERAL ATLANTIC, L.P. | ALHC | Director, 10% Owner | Sep 12 '25 | Sell | $16.01 | 13,460,000 | $215,494,600.00 | 24,596,079 | |
| General Atlantic (ALN HLTH), L.P. | ALHC | Director, 10% Owner | Sep 12 '25 | Sell | $16.01 | 13,460,000 | $215,494,600.00 | 24,596,079 | |
| Scavo Robert L. | ALHC | Chief Information Officer | Sep 10 '25 | Sell | $16.54 | 29,535 | $484,599.97 | 580,967 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Sep 10 '25 | Sell | $16.50 | 535,018 | $8,779,960.71 | 4,634,678 | |
| Maroney Dawn Christine | ALHC | President | Sep 10 '25 | Sell | $16.50 | 215,662 | $3,539,433.56 | 1,797,237 | |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Sep 10 '25 | Sell | $16.54 | 30,939 | $507,635.76 | 352,403 | |
| KONOWIECKI JOSEPH S | ALHC | Director | Sep 9 '25 | Sell | $17.00 | 25,000 | $425,000.00 | 1,110,973 |
Latest Alignment Healthcare Inc. News
ALHC Breaking Stock News: Dive into ALHC Ticker-Specific Updates for Smart Investing
GlobeNewswire
25 days ago
Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy
MT Newswires
a month ago
Alignment Healthcare Insider Sold Shares Worth $396,800, According to a Recent SEC Filing
StockStory
a month ago
3 Growth Stocks to Stash
StockStory
3 months ago
5 Must-Read Analyst Questions From Alignment Healthcare’s Q1 Earnings Call
StockStory
3 months ago
2 Unprofitable Stocks with Exciting Potential and 1 to Turn Down
MT Newswires
4 months ago
Alignment Healthcare Insider Sold Shares Worth $1,302,849, According to a Recent SEC Filing
Simply Wall St.
4 months ago
Breakeven On The Horizon For Alignment Healthcare, Inc. (NASDAQ:ALHC)
MT Newswires
4 months ago
Alignment Healthcare Insider Sold Shares Worth $296,042, According to a Recent SEC Filing
Compare ALHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.